Biography
Dr. Matthew Y.C. Lin is a gastrointestinal and acute care surgeon who specializes in minimally invasive surgery of the upper digestive tract. Dr. Lin treats conditions of the bile ducts, esophagus, gallbladder, intestines and stomach.
Dr. Lin received his medical degree at the David Geffen School of Medicine at UCLA, followed by a general surgery residency at Harbor – UCLA Medical Center. He then completed a fellowship in minimally invasive and bariatric surgery at UCSF. He subsequently joined the Department of Surgery faculty as a member of the Division of General Surgery, Section of Gastrointestinal Surgery.
During his career, Dr. Lin has been keenly focused on medical and surgical education. He has earned certificates from the UCSF Teaching Scholars Program (TSP) and the UCSF Training in Clinical Research (TICR) Program.
In 2017, Dr. Lin was appointed Associate Director of the Surgery Clerkship at the UCSF School of Medicine. UCSF has consistently ranked among the top progrrams for surgical education of medical students by US News and World Report. Dr. Lin also serves as Surgery Clerkship Site Director at UCSF Parnassus and as PISCES Surgery Liaison for third year medical students, overseeing the surgical curriculum and pairing students with surgery preceptors.
In 2019, Dr. Lin was inducted into the prestigious Haile T. Debas Academy of Medical Educators.
In addition to medical and surgical education, Dr. Lin's research interests include advanced foregut endoscopy, rescue therapies for weight regain, complex hernia repairs, acute care surgery, bariatric surgery, and robotic surgery.
Dr. Lin serves on the American Society for Metabolic and Bariatric Surgery Emergent Technology Committee and the American Hernia Society Membership Committee, and is a member of the American College of Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons. He has also published numerous peer-reviewed articles in his fields of interest.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of California | Diversity, Equity, and Inclusion Champion Training | 2017 | |
University of California Los Angeles | M.D. | School of Medicine | 2005 |
Board Certifications
American Board of Surgery, General Surgery
Clinical Expertise
Achalasia
Barrett's Esophagus
Gastroesophageal Reflux Disease (GERD)
Gallstones (Cholelithiasis)
Gastrointestinal Carcinoid Tumors
Inguinal Hernia
Small Intestine Cancer
Gastrointestinal Stromal Tumor (GIST)
Stomach (Gastric) Cancer
In the News
Research Interests
Medical and Surgical education
Long-term outcomes for Heller myotomy
Laparoscopic Sleeve Gastrectomy for Pre-transplant Candidates
Laparoscopic Roux-en-Y Gastric Bypass for Morbidly Obese Undergoing Lung Transplantation
Laparoscopic Sleeve Gastrectomy (LSG) in Morbidly Obese Patients Awaiting Liver Transplantation and in Post-Transplant setting
Publications
- Lowering the Barrier of Surgical Endoscopy With a Novel Articulating Retractor.| | UCSF Research Profile
- Peer video review and feedback improve performance in basic surgical skills.| | PubMed
- Expanded indications for bariatric surgery: should patients on chronic steroids be offered bariatric procedures?| | PubMed
- A123 The Benefit and Cost Effectiveness of Laparoscopic Gastric Bypass Stems Largely From Resolution of Metabolic Disease, Not Just Weight Loss.| | UCSF Research Profile
- Morbidity and Mortality Associated With Elective or Emergency Paraesophageal Hernia Repair.| | PubMed
- A prospective, randomized controlled trial of single-incision laparoscopic vs conventional 3-port laparoscopic appendectomy for treatment of acute appendicitis.| | PubMed
- Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates.| | PubMed
- A public hospital experience with young gastric cancer patients.| | UCSF Research Profile
- Laparoscopic Sleeve Gastrectomy (LSG) Is Safe, Well Tolerated and Improves Candidacy in Morbidly Obese Patients Awaiting Liver Transplantation.| | UCSF Research Profile
- Laparoscopic Sleeve Gastrectomy (LSG) Is Safe, Well Tolerated and Improves Candidacy in Morbidly Obese Patients Awaiting Liver Transplantation.| | UCSF Research Profile